Analyses of cancer data from three ezetimibe trials

N Engl J Med. 2009 Jan 1;360(1):86-7; author reply 87. doi: 10.1056/NEJMc082188.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / adverse effects*
  • Azetidines / adverse effects*
  • Data Interpretation, Statistical
  • Ezetimibe
  • Humans
  • Hypercholesterolemia / drug therapy
  • Neoplasms / chemically induced*
  • Neoplasms / mortality
  • Randomized Controlled Trials as Topic
  • Risk

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Ezetimibe